Bruker Reports Third Quarter 2021 Financial Results

Go back to Bruker Reports Third Quarter 2021 Financial Results

Bruker (BRKR) PT Raised to $90 at Cowen

November 3, 2021 6:36 AM EDT

Cowen analyst Max Masucci raised the price target on Bruker (NASDAQ: BRKR) to $90.00 (from $68.00) while maintaining a Market Perform rating.

The analyst commented, "BRKR delivered a solid Q3 update and raised its FY'21 guide for the third time this year. Valuation... More

Bruker (BRKR) Tops Q3 EPS by 19c

November 1, 2021 4:13 PM EDT

Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.63, $0.19 better than the analyst estimate of $0.44. Revenue for the quarter came in at $608.9 million versus the consensus estimate of $574.17 million.

GUIDANCE:

Bruker sees FY2021 EPS of $2.05-$2.09, versus the consensus of $1.93.

For earnings history and earnings-related data on Bruker (BRKR) click here.

... More